Delivery Order SPE2DB20D3103-SPE2DB23FM2U1

Award Date 1/26/23
Potential Completion Date 1/27/23
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of 4,565,294,512 units of 4% lidocaine hydrochloride solution in 4 mL vials, with a ceiling value of $1,516.98 and a completion date of July 31, 2024. This delivery order is not designated as a set-aside contract....
This federal contract award is for the delivery of Lidocaine HCL 1% ampules to the Defense Logistics Agency (DLA). The $1,224.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Lidocaine HCl 1% vials. The $1,338.00 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.64 firm fixed-price delivery order is for the supply of 50 ml vials of 1% Lidocaine HCL, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% vials, valued at $1,351.13, with a completion date of March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $2,824.37, is for the delivery of a specific medical product - Lidocaine HCL 2% 200 mg/10 mL. The contract is a firm fixed-price Delivery Order with a completion date of June 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,702.82 firm fixed-price delivery order is for the supply of 4% Lidocaine HCL Ampul, 5 ML. The contract has an ultimate completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Lidocaine HCL 2% 200 mg/10 mL 10 mL to the Defense Logistics Agency (DLA). The $2,086.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of December 6, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,114.40 firm fixed-price delivery order is for the procurement of 4566619544 - Lidocaine HCL 5ML 25S medical supplies. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not designated with any set-aside...
This federal contract award is for the delivery of Lidocaine HCL 1% in 10 ml vials, valued at $1,991.04, from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 30, 2024 and was awarded on April 29, 2024 with a firm fixed price. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM2U1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The delivery order is for the supply of 4559738273 - Lidocaine HCL 1% Vial 2ML, a pharmaceutical product, at a ceiling value of $1,524.90. The contract is a firm-fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, is a critical supplier of essential medical commodities, including specialty medications, generic drugs, and medical devices, to support military healthcare programs globally through this and other IDCs with federal agencies such as the Department of Justice Federal Bureau of Investigation.

Generated 2/27/25, 10:16 AM